5108-103A: 3D Image-guided Prone Breast Biopsy:
Initial Clinical Experience ARCHIVE
Recording of a live webinar presented on Tuesday • March 7, 2017
A certified one-hour archived webinar for radiologists, radiologic technologists, and other healthcare providers who manage patients with breast disease
This course expires April 1, 2022
If you want credit, this course must be completed (i.e. view course content (PDF file), pass the posttest, AND print the certificate) by no later than March 31, 2022 by 5:00PM
Please note, after this course has expired, no aspect of the course will be accessible, including the course link.
Format: | Archived Webinar |
Credit: | 1.0 AMA PRA Category 1 |
Credit: | 1.0 ARRT Category A |
Tuition: | none |
Course Overview
Given its exquisite ability to pinpoint a lesion, stereotactic breast biopsy remains a reliable and accurate means for sampling and diagnosis of mammographically-detected breast lesions. Breast stereotaxis offers obvious benefits to both patient and practitioner compared to needle wire localization and open surgical biopsy. Given the advent of 3D image-guided prone stereotaxis, breast imagers and interventionalists may now add another minimally invasive, safe, and accurate biopsy technique to their portfolio of image-guided breast biopsy options.
Educational Objectives
At the conclusion of this activity, participants should be better able to:
Physician Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and International Center for Postgraduate Medical Education. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
SA-CME: This activity meets the criteria for self-assessment toward the purpose of fulfilling requirements in the American Board of Radiology (ABR) Maintenance of Certification Program.
The European Accreditation Council for CME (EACCME®)
The UEMS-EACCME® has mutual recognition agreements with the American Medical Association (AMA) for live event and e-learning materials. For more information go to https://www.ama-assn.org/education/uemseaccme-cme-credit-recognition .
Radiologic Technologists Continuing Education
This program has been approved by the American Society of Radiologic Technologists (ASRT) for 1.0 hour of ARRT Category A continuing education credit.
How to Participate
There are no fees or prerequisites to participate in this program.
Faculty
Debbie Lee Bennett, MD
Director, Breast Imaging
St. Louis University Hospital
Assistant Professor of Radiology
St. Louis University School of Medicine
St. Louis, MO
After receiving her medical degree from Harvard University School of Medicine, Dr. Bennett completed her internship in internal medicine at Vanderbilt University Medical Center, followed by a residency in diagnostic radiology at Massachusetts General Hospital where she served as Chief Resident. Her fellowship in breast imaging was completed at Massachusetts General Hospital.
In addition to her clinical and teaching responsibilities, Dr. Bennett is well-published in peer-reviewed journals and co-authored a book chapter on sonographic techniques for early detection of ovarian and endometrial cancers. She also serves on committees for the Society of Breast Imaging and Radiological Society of North America.
Dr. Bennett is a featured speaker at medical meetings and local and state breast cancer support groups and regularly appears in the local media where she advocates for preventative women’s health.
Disclosure Information
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for anyone in a position to control content will be disclosed to participants prior to the start of each activity.
Debbie L. Bennett, MD, has NO conflicts to report.
The following planners and managers have reported NO financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Trace Hutchison, PharmD
Samantha Mattiucci, PharmD, CHCP
Linda McLean, MS
Victoria Phoenix, BS
Jan Schultz, MSN, RN, CHCP
Judi Smelker-Mitchek, MBA, MSN, RN
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Questions
For questions regarding this program, please contact ICPME:
Email: information@icpmed.com
Jointly provided by
This activity is supported by an independent grant from Hologic, Inc.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.